TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development TRU Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism SOHOO Q2 2025 Earnings Preferred Dividend Coverage Strengthens Amid Steady Hotel Operations LYEL Q1 2026 Earnings EPS Surpasses Estimates Despite Continued Revenue Absence PRIM Q1 2026 Earnings EPS Misses Estimates by Over 31 Stock Edges Higher